Cargando…
Insulin‐like growth factor‐2 is a promising candidate for the treatment and prevention of Alzheimer's disease
Alzheimer's disease (AD) is the most common form of dementia. Current AD treatments slow the rate of cognitive decline, but do not restore lost function. One reason for the low efficacy of current treatments is that they fail to target neurotrophic processes, which are thought to be essential f...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173726/ https://www.ncbi.nlm.nih.gov/pubmed/36971212 http://dx.doi.org/10.1111/cns.14160 |